title: Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles.
abstract: Owing to increasing rates of hypertension and cardiovascular-related diseases in developing countries, compliance with antihypertensive medication is major public health importance. Few studies have reported on compliance in developing countries. We determined the compliance of 187 patients with uncontrolled hypertension in the Seychelles (Indian Ocean), by assessing the presence of a biologic marker (riboflavin) in the urine. The urine tested positive in 56% of the cases. Compliance varied from one physician to another (highest 72% versus lowest 33%, P = 0.003), improved with the level of literacy (62% versus 45%, P = 0.024), and depended on the presence absence of diuretics in the medication (respectively, 45% versus 66%, P = 0.005). The ability of patients to report correctly the number of antihypertensive pills to be taken daily was a predictor of compliance (62% of the patients who gave appropriate answers had positive urine for the marker versus 31% for those giving inappropriate answers).
authors.affiliation: Epidemiology and Research Unit, Ministry of Health, Victoria, Seychelles.
authors.forename: P
authors.initials: P
authors.lastname: Hungerbuhler
authors.forename: P
authors.initials: P
authors.lastname: Bovet
authors.forename: C
authors.initials: C
authors.lastname: Shamlaye
authors.forename: B
authors.initials: B
authors.lastname: Burnand
authors.forename: B
authors.initials: B
authors.lastname: Waeber
mesh_terms: D000368:Aged; D001294:Attitude to Health; D015415:Biomarkers / Q000652:urine; D003710:Demography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000523:psychology; D008019:Life Style; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012256:Riboflavin / Q000008:administration & dosage / Q000652:urine
chemical_list: D015415:Biomarkers; D012256:Riboflavin